Arbutus Biopharma (ABUS)'s 30-day implied volatility (IV30) was 49.8% at the close on November 10, 2026, up from 41.3% the day before, against a 52-week range of 29.7% to 167.9%. Its 20-day historical volatility was 48.8%.
Data as of November 10, 2026.